The race to produce vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
began when the first sequence was published, and this forms the basis for …

Background The relationship between the presence of antibodies to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains …

SARS-CoV-2 has caused over 2 million deaths in little over a year. Vaccines are being
deployed at scale, aiming to generate responses against the virus spike. The scale of the …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. …

We conducted voluntary Covid-19 testing programmes for symptomatic and asymptomatic
staff at a UK teaching hospital using naso-/oro-pharyngeal PCR testing and immunoassays for …

Background Lateral flow device (LFD) viral antigen immunoassays have been developed
around the world as diagnostic tests for SARS-CoV-2 infection. They have been proposed to …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin
G (IgG) antibody measurements can be used to estimate the proportion of a population …

Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses
PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been …

Background SARS-CoV-2 IgG antibody measurements can be used to estimate the
proportion of a population exposed or infected and may be informative about the risk of future …

Influenza is a major global public health threat as a result of its highly pathogenic variants,
large zoonotic reservoir, and pandemic potential. Metagenomic viral sequencing offers the …